The SocietyMore than 35,000 clinicians, scientists and allied health professionals from over 160 countries are part of the ERS communityBecome an ERS member
Please note: This page is continuously updated and therefore the information below is subject to change and new content may be added.
An abstract is a summary of a paper (research publication). The study and results reported should be novel and not simply an extension of previously published work.
Writing an abstract and submission for the ERS Congress is a great opportunity, as:
Submission is free.
Online: connect to myERS https://my.ersnet.org/ then choose the menu ‘Abstract/Cases’ and select Congress submission, then access abstracts platform.
Abstracts that are considered as late breaking must contain novel data and this data must became available for public dissemination only after the standard abstract deadline in February 2022.
The study and results reported should be novel and not simply an extension of previously published work. The late-breaking abstract round is not designed to favour investigators who unintentionally missed the deadline for the regular abstract submission.
Note that the submission is not free, €75 submission fee applies for each LBA submission (non-refundable). For people based in Switzerland additionally 8% VAT will apply.
The most ground-breaking RCT and very late-breaking clinical trial data from all respiratory disease areas. Best RCTs will be presented as part of the ‘Abstracts Leading to Evolution in Respiratory Medicine Trials’ sessions (ALERT).
Note that the submission is not free, €150 submission fee applies for each RCT abstract submission (non-refundable). For people based in Switzerland additionally 8% VAT will apply.
Abstracts are intended to present scientific studies and research. If your study is currently ongoing and you only have preliminary data, but it seems relevant or significant, you can submit the abstract. However please be aware that abstracts with incomplete data may have less chance of being accepted for the ERS International Congress.
After your abstract is accepted you cannot update the content of your abstract for the official publication as the accepted version will be published, however you are permitted to present updated information onsite at the Congress.
Title: The title should be an accurate description of the abstract’s contents. It should explain as much as possible about the context and the aims of the study. The title should be about 10–12 words long, and should include the scope of the investigation, the study design and the goal. The title should be a description of what was investigated rather than a statement of the results or conclusions. The abstract title should be easy for the reader to understand and should not include jargon or unfamiliar acronyms or abbreviations. The title should not be in capital letters.
Authors: The list of authors should be restricted to those individuals who carried out the study, conceived it, designed it, gathered the data, analysed the numbers and wrote the abstract. The author who will present the abstract should be listed first. Every listed author should read and approve the abstract before it is submitted.
Main text: A good abstract should address the five following questions in the relevant sections:
1. “Why did you start?” – Introduction or background / You should summarise, preferably in one sentence, the current knowledge specifically in relation to the work you are presenting.
2. “What did you try to do?” – Aims and objectives / State the aim of your study, and ideally include a short statement of the study’s hypothesis. A legitimate scientific study is not done “to prove that something is true” but rather “to find out whether it is true.” The distinction may seem small but it makes a significant difference. A formal hypothesis shows that you are objective.
3. “What did you do?” – Methods / In an abstract, the description of the methods has to be concise, and much of the details of what was done must be omitted. However, in a few short sentences, you can give the reader a good idea of the design of the study, the context in which it was done, and the types of patients or measurements that were included.
4. “What did you find?” – Results / It is important to give the main results of the study, not in subjective terms (“We found device X to be superior to device Y”) but also in the form of some real data. You will need to choose which findings to report here: it should be the most important data in your study, and the findings on which your conclusions will be based. Do not include a table or figure unless you need it to show your results.
5. “What does it mean?” – Conclusions / Here, space constraints generally limit you to a single sentence of why you think your findings are important, and their potential implications. Keep your conclusions reasonable and supportable by the findings of your study. Remember that if your study was restricted to certain patients, or a particular therapy, or a specific device, its results may not extend beyond these restrictions.
Please see the full guidelines for more information.
A maximum of three abstracts (including Late-breaking abstracts) may be submitted by the same author.
We do not encourage to submit the case study abstracts, however we accept them if they are well prepared. We do not provide specific templates for this kind of abstracts. You may however consider submission of Clinical Case by the 22nd February extended deadline.
Yes, when you are submitting your abstract(s) you will have the opportunity to disclose your conflict of interest. Conflict of interest statement is only required for the first author.
All accepted abstracts will be published in a supplement of the European Respiratory Journal (ERJ) by end of November 2022.
You must submit your RCT abstract online by logging in to myERS and choosing the ‘Abstract’ menu, and then select ‘Congress submission’. The submission period for RCT is from 20 – 30 June 2022.
Note that the submission is not free, €150.00 submission fee applies for each RCT abstract submission (non-refundable). For people based in Switzerland additionally 8% VAT will apply.
The publication of the data should not have occurred prior to the submission of the abstract for presentation at the ERS International Congress. In addition, the presentation of the original data should be presented for the first time to the audience at the ERS international congress.
While we understand that publication of the data in journals cannot be delayed, the presentation of the original data should be presented for the first time to the audience at the ERS international congress.
Copyright for abstracts is retained by authors (see on submission Terms & Agreement “11. Copyright, if this abstract is accepted, will be held by the author or employer (as part of the conditions of the author(s)’s employment).”)
The abstracts are not published under a creative commons framework (Creative Commons licencing is most generally used to ‘describe’ how you can ‘use/re-use’ an open access document). The abstracts are not published open access. They are free to access (on both the ERS platforms and when they are published as a supplement of the ERJ), which is different to open access, and are copyright to the author.
The maximum length of an abstract is 1,810 characters including characters and spaces in the following: Abstract Title, Abstract Body, Table, and Figures. N.B. if you insert a table, one character will be deducted per cell. If you insert an image/picture/figure, it will deduct 277 characters.
There is no limit regarding number of authors. However, the list of authors should be restricted to those individuals who carried out the study, conceived it, designed it, gathered the data, analysed the numbers and wrote the abstract. The author who will present the abstract should be listed first. Every listed author should read and approve the abstract before it is submitted.
All authors must have a myERS account. If the co-author does not have an account, they can create a myERS account for free.
The late-breaking abstract and RCT round is not the extension for the regular abstract submission deadline.
The status of your abstract(s) is now available on the same myERS account that has been used to submit the abstract, according to below timeline:
|Round||Call open / close dates||Notification timeline|
|First call||15 December – Extended deadline 22 February 2022 at 23:59 CET||15 June 2022.|
|Late-breaking abstracts (LBA)||2 May – 31 May 2022 at 23:59 CEST||mid-July 2022.|
|Randomised controlled trial abstracts (RCT)||20–30 June 2022 at 23:59 CEST||August 2022.|
For the details on allocation of your accepted abstract check the congress online programme.
Abstract presenting author need to submit the abstract’s congress materials using the: upload link
No, this information will only be available after you will receive the abstract’s notification email according to the submission round (1st round, LBA, RCT).
All abstracts are graded anonymously by a panel of at least three reviewers on a scale from one (lowest) to six (highest), with an average score of three minimum for acceptance, on the basis of the following criteria:
Based on these elements, the decision is taken to accept or reject abstracts for the congress. When allocation of abstracts into sessions begins, ERS officers also consider the limitations of slots available in the congress programme.
The information regarding type, date, time and room of the session that your abstract is accepted to, as well as the official ERS Congress abstract acceptance letter will be sent to the abstract presenters’ email address, and it will be available to download on the presenter’s personal space.
Full content of accepted abstracts will be visible in the online programme from 22rd of August 2022 as pre-congress content. This date excludes abstracts allocated in ALERT sessions and abstracts under embargo which will be visible on the day of the presentation.
You cannot modify your abstract’s body nor title after it is submitted with no exceptions.
After you receive the notification that your abstract is accepted to the ERS Congress, you will be able to modify only the list of authors via myERS.
To ensure that changes to the author’s list are considered, make sure the changes are done in due time, at least one month prior the Congress starts to ensure the abstract are updated on all platforms.
You will have to login to the abstract platform and edit the authors list or to change the presenting author.
To ensure that your abstract is withdrawn from the ERS 2022 Congress Programme send the completed form in due time, at least two weeks prior the Congress starts to ensure that all platforms are updated.
Change of the presenter can be done via myERS submitter account. Firstly, make sure the new presenter is on the list of co-authors, if not add new author to the list. Then for the change click the arrows icon on the right-hand side of the table with abstract’s title, then follow the instruction you will receive via email. This change will not be done until the new presenter accepts to present by completing the form available on the communicated link.
To change the list of authors (add, remove, change the order, change affiliation) click on the first left icon edit next to the abstract’s title, then access the list of authors for your further update.
Changes may take up to 48 hours to appear in the programme. Avoid leaving the presenter change until the last moment as the ERS Congress virtual platform may not be updated in time
Important: New presenter will have to upload abstract materials (ePoster or PPTX) from his/her account. If the presentation will be already uploaded by the old presenter, after the presenter change it will disappear from the Congress platform and will have to be re-uploaded by the new presenter.
Make sure you do not leave presenter change until the last moment as the ERS Virtual Congress platform may not be updated on time.
No, after you abstract is selected to the ERS Congress, the allocation (schedule and presentation type) is decided by the International Congress Programme Committee and you will have no option to modify this
Change of the presenting author can be done from the submitter’s myERS account.
Use the following link to upload your congress materials by the deadline, 31 July: UPLOAD LINK
Do not attach your ePoster or PowerPoint presentation to e-mails as they will not be processed!
Only upload via ERS congress online platform by the presenting author (using personal myERS credentials) is possible, use the: UPLOAD LINK to correctly upload your abstract materials to the ERS Congress 2022.
Posters accepted for the ERS International Congress (& other ERS Events) can include QR codes.
On the poster / next to the QR code, it should be disclaimed that the ERS is neither responsible, nor endorsing the data and information presented on the poster.
The website you will be leading the delegates to, should be in direct relation with the information presented on the poster and should NOT be an advertisement of a company/product
As an accepted abstract TP presenter, you will need to:
Use the link to upload your congress materials by the deadline: upload link
As an accepted abstract OP presenter, you will need to:
ERS Templates can be found here as recommendation, author can still use own template.
Yes you can, ERS Templates can be found here as recommendation, author can still use own template.
Yes, as an abstract’s presenter in the Thematic Poster session you will need to prepare and upload the: 1-page ePoster (PDF) + 5min audio narration, by the deadline 31st of July. It will be available from the 22nd of August as pre-congress content on the ERS Congress platform.
Use the link to upload your congress materials by the deadline: upload link
As an abstract’s presenter in the Oral Presentation session you will need to prepare and upload the: 1-page ePoster (PDF) + 5min audio narration, by the deadline 31st of July. It will be available from the 22nd of August as pre-congress content on the ERS Congress platform.
Use the link to upload your congress materials by the deadline: upload link
No you cannot, after you abstract is allocated to the ERS Congress you will have no option to modify the schedule and presentation type.
You may however change the presenter of your abstract that will be available to present the abstract.
Recommended specifications for e-poster:
ERS Templates can be found here as recommendation, author can still use own template
Note that all presenting authors must register for the Congress. If you have not yet registered, please remember that the 5th of July 2022 (23.59 CEST) is the deadline of the early-bird registration fee.
Onsite spaces are limited for this year congress, and early registration is recommended!
For further registration queries, check the congress registration website.
Notification to those who succeeded will be sent out in June 2022.
No, sponsorships and grants are specifically attributed to carefully selected candidates, rendering sponsorships and grants nontransferable.
No, the grant or sponsorship is related to your abstract submitted and accepted for the ERS International Congress 2022 and not any other ERS event.
No, grant or sponsorship is not offered for the late-breaking abstract submissions.